Article(id=1329832317138351036, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.09.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1687017600000, receivedDateStr=2023-06-18, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794986331495, onlineDateStr=2026-11-18, pubDate=1694275200000, pubDateStr=2023-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794986331495, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794986331495, creator=13701087609, updateTime=1794986331495, updator=13701087609, issue=Issue{id=1329832316572119996, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='9', pageStart='895', pageEnd='1016', issueExtLink='null', onlineDate='null', pubDate='1694275200000', pubDateStr='2023-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794986331360, creator='13701087609', updateTime=1794988494433, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329841389711503745, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329841389715698050, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329832316572119996, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=895, endPage=898, ext={EN=ArticleExt(id=1329832317352260541, articleId=1329832317138351036, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Diabetic nephropathy (DN) is the main factor leading to end-stage renal disease, but the types and effects of current therapeutic drugs are limited. Mineralocorticoid receptor antagonist (MRA) has certain renal protection effect in patients with DN, and its mechanism may be related to inhibiting inflammation, reducing renal fibrosis and improving oxidative stress imbalance. This article further summarized the effects of MRA on DN, in order to provide some reference for clinical diagnosis and treatment.

, authors=Yeping YANG, Zhaoyun ZHANG*, authorsList=Yeping YANG, Zhaoyun ZHANG, authorCompany=null, correspAuthors=Zhaoyun ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329832317599724478, articleId=1329832317138351036, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=盐皮质激素受体拮抗剂治疗糖尿病肾病研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

糖尿病肾病(diabetic nephropathy,DN)是导致终末期肾病(end-stage renal disease)的主要因素,但目前治疗药物种类及效果均有限。盐皮质激素受体拮抗剂(mineralocorticoid receptor antagonist,MRA)对DN患者具有一定肾脏保护作用,其机制可能与抑制炎症、减少肾脏纤维化及改善氧化应激失衡等有关。现就MRA对DN的影响作进一步归纳、总结,旨在为临床诊治提供一定参考。

, authors=杨叶萍, 张朝云*, authorsList=杨叶萍, 张朝云, authorCompany=null, correspAuthors=张朝云, authorNote=

杨叶萍,住院医师,研究方向:糖尿病并发症。

, correspAuthorsNote=
张朝云,主任医师,研究方向:糖尿病并发症。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=McDa106jeDeEoy0/6sCHpA==, magXml=a+mCqvZHrB8+dLjD7EoFzQ==, pdfUrl=null, pdf=gNj+NRyKnZOqqlxZ7Rg5sw==, pdfFileSize=1535564, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=8mrHbOrbCbW6PWNryi4B2g==, mapNumber=null, fund=null)}, authors=[Author(id=1329832318061097923, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832318140789702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318061097923, language=EN, stringName=Yeping YANG, firstName=Yeping, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832318216287175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318061097923, language=CN, stringName=杨叶萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属华山医院内分泌科,上海 200040, bio={"content":"

杨叶萍,住院医师,研究方向:糖尿病并发症。

"}, bioImg=null, bioContent=

杨叶萍,住院医师,研究方向:糖尿病并发症。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832317956240319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, xref=null, ext=[AuthorCompanyExt(id=1329832317960434624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1329832317981406145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院内分泌科,上海 200040)])]), Author(id=1329832318275007433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329832318342116299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318275007433, language=EN, stringName=Zhaoyun ZHANG, firstName=Zhaoyun, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832318396642252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318275007433, language=CN, stringName=张朝云, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=复旦大学附属华山医院内分泌科,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832317956240319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, xref=null, ext=[AuthorCompanyExt(id=1329832317960434624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1329832317981406145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院内分泌科,上海 200040)])])], keywords=[Keyword(id=1329832318493111245, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=EN, orderNo=1, keyword=mineralocorticoid receptor antagonist), Keyword(id=1329832318547637198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=EN, orderNo=2, keyword=diabetic nephropathy), Keyword(id=1329832318602163151, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=EN, orderNo=3, keyword=renal fibrosis), Keyword(id=1329832318660883408, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=CN, orderNo=1, keyword=盐皮质激素受体拮抗剂), Keyword(id=1329832318719603665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=CN, orderNo=2, keyword=糖尿病肾病), Keyword(id=1329832318778323922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, language=CN, orderNo=3, keyword=肾脏纤维化)], refs=[Reference(id=1329832320690926550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=The EMPA-KIDNEY collaborative group. Empagliflozin and progression of kidney disease in type 2 diabetes[J]. N Engl J Med, 2023, 388(2): 117-127., articleTitle=null, refAbstract=null), Reference(id=1329832320783201239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Schjoedt KJ, Schjoedt KJ, Juhl TR, et al. Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy[J]. Kidney Int, 2006, 70(3): 536-542., articleTitle=null, refAbstract=null), Reference(id=1329832320837727192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Sato A, Hayashi K, Saruta T. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease[J]. Am J Hypertens, 2005, 18(1): 44-49., articleTitle=null, refAbstract=null), Reference(id=1329832320913224665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Bakris GL, Agarwal R, Chan JC, et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial[J]. J Am Med Assoc, 2015, 314(9): 884-894., articleTitle=null, refAbstract=null), Reference(id=1329832320988722138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Bakris GL, Agarwal L, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes[J]. N Engl J Med, 2020, 383(23): 2219-2229., articleTitle=null, refAbstract=null), Reference(id=1329832321060025307, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Filippatos G, Anker SD, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes[J]. Circulation, 2022, 145(6): 437-447., articleTitle=null, refAbstract=null), Reference(id=1329832321118745564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo C, Martinez-Vasquez D, Mendez GP, et al. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus[J]. Endocrinology, 2006, 147(11): 5363-5373., articleTitle=null, refAbstract=null), Reference(id=1329832321181660125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Lachaux M, Barrera-Chimal J, Nicol L, et al. Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction[J]. Diabetes Obes Metab, 2018, 20(10): 2399-2407., articleTitle=null, refAbstract=null), Reference(id=1329832321269740510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Mavrakanas TA, Gariani K, Martin PY. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review[J]. Eur J Intern Med, 2014, 25(2): 173-176., articleTitle=null, refAbstract=null), Reference(id=1329832321332655071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Ito S, Kashihara N, Shikata K, et al. Esaxerenone (CS-3150) in patients with type 2 diabetes and microalbuminuria (ESAX-DN): phase 3 randomized controlled clinical trial[J]. Clin J Am Soc Nephrol, 2020, 15(12): 1715-1727., articleTitle=null, refAbstract=null), Reference(id=1329832321395569632, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Barrera-Chimal J, Girerd S, Jaisser F. Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis[J]. Kidney Int, 2019, 96(2): 302-319., articleTitle=null, refAbstract=null), Reference(id=1329832321462678497, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system[J]. Nat Rev Nephrol, 2010, 6(5): 261-273., articleTitle=null, refAbstract=null), Reference(id=1329832321571730402, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology[J]. Pharmacol Rev, 2016, 68(1): 49-75., articleTitle=null, refAbstract=null), Reference(id=1329832321626256355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Taira M, Toba H, Murakami M, et al. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats[J]. Eur J Pharmacol, 2008, 589(1-3): 264-271., articleTitle=null, refAbstract=null), Reference(id=1329832321705948132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Amazit L, Le Billan F, Kolkhof P, et al. Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1[J]. J Biol Chem, 2015, 290(36): 21876-21889., articleTitle=null, refAbstract=null), Reference(id=1329832321773056997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Blasi ER, Rocha R, Rudolph AE, et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats[J]. Kidney Int, 2003, 63(5): 1791-1800., articleTitle=null, refAbstract=null), Reference(id=1329832321861137382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Barrera-Chimal J, Estrela GR, Lechner SM, et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling[J]. Kidney Int, 2018, 93(6): 1344-1355., articleTitle=null, refAbstract=null), Reference(id=1329832321928246247, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Armanini D, Endres S, Kuhnle U, et al. Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen[J]. Acta Endocrinol (Copenh), 1988, 118(4): 479-482., articleTitle=null, refAbstract=null), Reference(id=1329832321982772200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun XN, Li C, Liu Y, et al. T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-γ[J]. Circ Res, 2017, 120(10): 1584-1597., articleTitle=null, refAbstract=null), Reference(id=1329832322037298153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Li C, Sun XN, Zeng MR, et al. Mineralocorticoid receptor deficiency in T cells attenuates pressure overload-induced cardiac hypertrophy and dysfunction through modulating T-cell activation[J]. Hypertension, 2017, 70(1): 137-147., articleTitle=null, refAbstract=null), Reference(id=1329832322100212714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun Y, Zhang J, Zhang JQ, et al. Local angiotensinⅡ and transforming growth factor-β1 in renal fibrosis of rats[J]. Hypertension, 2000, 35(5): 1078-1084., articleTitle=null, refAbstract=null), Reference(id=1329832322171515883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Nagai Y, Miyata K, Sun GP, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts[J]. Hypertension, 2005, 46(4): 1039-1045., articleTitle=null, refAbstract=null), Reference(id=1329832322242819052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen D, Chen Z, Park C, et al. Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms[J]. Gene, 2013, 531(1): 23-30., articleTitle=null, refAbstract=null), Reference(id=1329832322326705133, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang LL, Nikolic-Paterson DJ, Ma FY, et al. Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling[J]. Nephron Exp Nephrol, 2012, 120(4): e115-e122., articleTitle=null, refAbstract=null), Reference(id=1329832322402202606, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Miyata K, Rahman M, Shokoji T, et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells[J]. J Am Soc Nephrol, 2005, 16(10): 2906-2912., articleTitle=null, refAbstract=null), Reference(id=1329832322473505775, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Keidar S, Kaplan M, Pavlotzky E, et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin Ⅱ and aldosterone[J]. Circulation, 2004, 109(18): 2213-2220., articleTitle=null, refAbstract=null), Reference(id=1329832322565780464, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Barrera-Chimal J, Prince S, Fadel F, et al. Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia[J]. J Am Soc Nephrol, 2016, 27(2): 398-404., articleTitle=null, refAbstract=null), Reference(id=1329832322645472241, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Bhuiyan AS, Rafiq K, Kobara H, et al. Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice[J]. Hypertens Res, 2019, 42(6): 892-902., articleTitle=null, refAbstract=null), Reference(id=1329832322708386802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Pessôa BS, Peixoto EB, Papadimitriou A, et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat[J]. J Renin Angiotensin Aldosterone Syst, 2012, 13(1): 56-66., articleTitle=null, refAbstract=null), Reference(id=1329832322775495667, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Silva MA, Bruder-Nascimento T, Cau SB, et al. Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling[J]. Front Physiol, 2015, 6: 269., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329832320401519571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, awardId=82170841; 81970716; 82100882; 82200921, language=CN, fundingSource=国家自然科学基金项目(82170841; 81970716; 82100882; 82200921), fundOrder=null, country=null), Fund(id=1329832320472822740, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, awardId=Z-2017-26-1902, language=CN, fundingSource=中华国际医学交流基金项目(Z-2017-26-1902), fundOrder=null, country=null), Fund(id=1329832320581874645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, awardId=3030255001, language=CN, fundingSource=上海医苑新星杰出人才培养计划(3030255001), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329832317956240319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, xref=null, ext=[AuthorCompanyExt(id=1329832317960434624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1329832317981406145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院内分泌科,上海 200040)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.09.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.09.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.09.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.09.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1694275200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
盐皮质激素受体拮抗剂治疗糖尿病肾病研究进展
杨叶萍 , 张朝云 *
世界临床药物 | 医药专论 2023,44(9): 895-898
收起
收藏切换
世界临床药物 |医药专论 2023 , 44 (9) : 895 -898
盐皮质激素受体拮抗剂治疗糖尿病肾病研究进展
全屏
[Author(id=1329832318061097923, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329832318140789702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318061097923, language=EN, stringName=Yeping YANG, firstName=Yeping, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832318216287175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318061097923, language=CN, stringName=杨叶萍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属华山医院内分泌科,上海 200040, bio={"content":"

杨叶萍,住院医师,研究方向:糖尿病并发症。

"}, bioImg=null, bioContent=

杨叶萍,住院医师,研究方向:糖尿病并发症。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832317956240319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, xref=null, ext=[AuthorCompanyExt(id=1329832317960434624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1329832317981406145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院内分泌科,上海 200040)])]), Author(id=1329832318275007433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329832318342116299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318275007433, language=EN, stringName=Zhaoyun ZHANG, firstName=Zhaoyun, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329832318396642252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, authorId=1329832318275007433, language=CN, stringName=张朝云, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=复旦大学附属华山医院内分泌科,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329832317956240319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, xref=null, ext=[AuthorCompanyExt(id=1329832317960434624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China), AuthorCompanyExt(id=1329832317981406145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329832317138351036, companyId=1329832317956240319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属华山医院内分泌科,上海 200040)])])]
杨叶萍, 张朝云*
作者信息
  • 复旦大学附属华山医院内分泌科,上海 200040
通讯作者:
张朝云,主任医师,研究方向:糖尿病并发症。
作者简介:

杨叶萍,住院医师,研究方向:糖尿病并发症。

Research progress on mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
Yeping YANG, Zhaoyun ZHANG*
Affiliations
  • Department of Endocrinology, Huashan Hospital, Fudan University, Shanghai 200040, China
出版时间: 2023-09-10 doi: 10.13683/j.wph.2023.09.001
文章导航
收藏切换

糖尿病肾病(diabetic nephropathy,DN)是导致终末期肾病(end-stage renal disease)的主要因素,但目前治疗药物种类及效果均有限。盐皮质激素受体拮抗剂(mineralocorticoid receptor antagonist,MRA)对DN患者具有一定肾脏保护作用,其机制可能与抑制炎症、减少肾脏纤维化及改善氧化应激失衡等有关。现就MRA对DN的影响作进一步归纳、总结,旨在为临床诊治提供一定参考。

盐皮质激素受体拮抗剂  /  糖尿病肾病  /  肾脏纤维化

Diabetic nephropathy (DN) is the main factor leading to end-stage renal disease, but the types and effects of current therapeutic drugs are limited. Mineralocorticoid receptor antagonist (MRA) has certain renal protection effect in patients with DN, and its mechanism may be related to inhibiting inflammation, reducing renal fibrosis and improving oxidative stress imbalance. This article further summarized the effects of MRA on DN, in order to provide some reference for clinical diagnosis and treatment.

mineralocorticoid receptor antagonist  /  diabetic nephropathy  /  renal fibrosis
杨叶萍, 张朝云. 盐皮质激素受体拮抗剂治疗糖尿病肾病研究进展. 世界临床药物, 2023 , 44 (9) : 895 -898 . DOI: 10.13683/j.wph.2023.09.001
Yeping YANG, Zhaoyun ZHANG. Research progress on mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy[J]. World Clinical Drug, 2023 , 44 (9) : 895 -898 . DOI: 10.13683/j.wph.2023.09.001
  • 国家自然科学基金项目(82170841; 81970716; 82100882; 82200921)
  • 中华国际医学交流基金项目(Z-2017-26-1902)
  • 上海医苑新星杰出人才培养计划(3030255001)
参考文献 引证文献
排序方式:
[1]
The EMPA-KIDNEY collaborative group. Empagliflozin and progression of kidney disease in type 2 diabetes[J]. N Engl J Med, 2023, 388(2): 117-127.
[2]
Schjoedt KJ, Schjoedt KJ, Juhl TR, et al. Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy[J]. Kidney Int, 2006, 70(3): 536-542.
[3]
Sato A, Hayashi K, Saruta T. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease[J]. Am J Hypertens, 2005, 18(1): 44-49.
[4]
Bakris GL, Agarwal R, Chan JC, et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial[J]. J Am Med Assoc, 2015, 314(9): 884-894.
[5]
Bakris GL, Agarwal L, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes[J]. N Engl J Med, 2020, 383(23): 2219-2229.
[6]
Filippatos G, Anker SD, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes[J]. Circulation, 2022, 145(6): 437-447.
[7]
Guo C, Martinez-Vasquez D, Mendez GP, et al. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus[J]. Endocrinology, 2006, 147(11): 5363-5373.
[8]
Lachaux M, Barrera-Chimal J, Nicol L, et al. Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction[J]. Diabetes Obes Metab, 2018, 20(10): 2399-2407.
[9]
Mavrakanas TA, Gariani K, Martin PY. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review[J]. Eur J Intern Med, 2014, 25(2): 173-176.
[10]
Ito S, Kashihara N, Shikata K, et al. Esaxerenone (CS-3150) in patients with type 2 diabetes and microalbuminuria (ESAX-DN): phase 3 randomized controlled clinical trial[J]. Clin J Am Soc Nephrol, 2020, 15(12): 1715-1727.
[11]
Barrera-Chimal J, Girerd S, Jaisser F. Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis[J]. Kidney Int, 2019, 96(2): 302-319.
[12]
Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system[J]. Nat Rev Nephrol, 2010, 6(5): 261-273.
[13]
Jaisser F, Farman N. Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology[J]. Pharmacol Rev, 2016, 68(1): 49-75.
[14]
Taira M, Toba H, Murakami M, et al. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats[J]. Eur J Pharmacol, 2008, 589(1-3): 264-271.
[15]
Amazit L, Le Billan F, Kolkhof P, et al. Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1[J]. J Biol Chem, 2015, 290(36): 21876-21889.
[16]
Blasi ER, Rocha R, Rudolph AE, et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats[J]. Kidney Int, 2003, 63(5): 1791-1800.
[17]
Barrera-Chimal J, Estrela GR, Lechner SM, et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling[J]. Kidney Int, 2018, 93(6): 1344-1355.
[18]
Armanini D, Endres S, Kuhnle U, et al. Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen[J]. Acta Endocrinol (Copenh), 1988, 118(4): 479-482.
[19]
Sun XN, Li C, Liu Y, et al. T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-γ[J]. Circ Res, 2017, 120(10): 1584-1597.
[20]
Li C, Sun XN, Zeng MR, et al. Mineralocorticoid receptor deficiency in T cells attenuates pressure overload-induced cardiac hypertrophy and dysfunction through modulating T-cell activation[J]. Hypertension, 2017, 70(1): 137-147.
[21]
Sun Y, Zhang J, Zhang JQ, et al. Local angiotensinⅡ and transforming growth factor-β1 in renal fibrosis of rats[J]. Hypertension, 2000, 35(5): 1078-1084.
[22]
Nagai Y, Miyata K, Sun GP, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts[J]. Hypertension, 2005, 46(4): 1039-1045.
[23]
Chen D, Chen Z, Park C, et al. Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms[J]. Gene, 2013, 531(1): 23-30.
[24]
Huang LL, Nikolic-Paterson DJ, Ma FY, et al. Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling[J]. Nephron Exp Nephrol, 2012, 120(4): e115-e122.
[25]
Miyata K, Rahman M, Shokoji T, et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells[J]. J Am Soc Nephrol, 2005, 16(10): 2906-2912.
[26]
Keidar S, Kaplan M, Pavlotzky E, et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin Ⅱ and aldosterone[J]. Circulation, 2004, 109(18): 2213-2220.
[27]
Barrera-Chimal J, Prince S, Fadel F, et al. Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia[J]. J Am Soc Nephrol, 2016, 27(2): 398-404.
[28]
Bhuiyan AS, Rafiq K, Kobara H, et al. Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice[J]. Hypertens Res, 2019, 42(6): 892-902.
[29]
Pessôa BS, Peixoto EB, Papadimitriou A, et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat[J]. J Renin Angiotensin Aldosterone Syst, 2012, 13(1): 56-66.
[30]
Silva MA, Bruder-Nascimento T, Cau SB, et al. Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling[J]. Front Physiol, 2015, 6: 269.
2023年第44卷第9期
20
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.09.001
  • 接收时间:2023-06-18
  • 首发时间:2026-11-18
  • 出版时间:2023-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-06-18
基金
国家自然科学基金项目(82170841; 81970716; 82100882; 82200921)
中华国际医学交流基金项目(Z-2017-26-1902)
上海医苑新星杰出人才培养计划(3030255001)
作者信息
    复旦大学附属华山医院内分泌科,上海 200040

通讯作者:

张朝云,主任医师,研究方向:糖尿病并发症。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.09.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏